These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36707813)
1. Three nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis. Liao Y; Cai H; Luo F; Li D; Li H; Liao G; Duan J; Xu R; Zhang X BMC Med Genomics; 2023 Jan; 16(1):15. PubMed ID: 36707813 [TBL] [Abstract][Full Text] [Related]
2. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. Cheng Q; Chen X; Wu H; Du Y J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Liguori M; Nuzziello N; Introna A; Consiglio A; Licciulli F; D'Errico E; Scarafino A; Distaso E; Simone IL Front Mol Neurosci; 2018; 11():288. PubMed ID: 30210287 [TBL] [Abstract][Full Text] [Related]
4. Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes. Gascón E; Zaragoza P; Calvo AC; Osta R Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540795 [TBL] [Abstract][Full Text] [Related]
5. Screening and identification of key biomarkers associated with amyotrophic lateral sclerosis and depression using bioinformatics. Wang Z; Yang H; Han Y; Teng J; Kong X; Qi X Medicine (Baltimore); 2023 Nov; 102(47):e36265. PubMed ID: 38013317 [TBL] [Abstract][Full Text] [Related]
6. Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis. Patel RB; Bajpai AK; Thirumurugan K J Mol Neurosci; 2023 Jun; 73(6):375-390. PubMed ID: 37249795 [TBL] [Abstract][Full Text] [Related]
7. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Daneshafrooz N; Joghataei MT; Mehdizadeh M; Alavi A; Barati M; Panahi B; Teimourian S; Zamani B Sci Rep; 2022 Jan; 12(1):1373. PubMed ID: 35082326 [TBL] [Abstract][Full Text] [Related]
8. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. De Felice B; Annunziata A; Fiorentino G; Borra M; Biffali E; Coppola C; Cotrufo R; Brettschneider J; Giordana ML; Dalmay T; Wheeler G; D'Alessandro R Neurogenetics; 2014 Oct; 15(4):243-53. PubMed ID: 25130371 [TBL] [Abstract][Full Text] [Related]
9. RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery. Grima N; Liu S; Southwood D; Henden L; Smith A; Lee A; Rowe DB; D'Silva S; Blair IP; Williams KL Neuropathol Appl Neurobiol; 2023 Dec; 49(6):e12943. PubMed ID: 37818590 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis. Panio A; Cava C; D'Antona S; Bertoli G; Porro D Front Med (Lausanne); 2022; 9():861960. PubMed ID: 35602517 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-5572 Is a Novel MicroRNA-Regulating Kurita H; Yabe S; Ueda T; Inden M; Kakita A; Hozumi I Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599739 [TBL] [Abstract][Full Text] [Related]
12. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046 [TBL] [Abstract][Full Text] [Related]
13. Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis. Cheng YF; Gu XJ; Yang TM; Wei QQ; Cao B; Zhang Y; Shang HF; Chen YP Front Aging Neurosci; 2023; 15():1106497. PubMed ID: 36845651 [TBL] [Abstract][Full Text] [Related]
14. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. De Felice B; Guida M; Guida M; Coppola C; De Mieri G; Cotrufo R Gene; 2012 Oct; 508(1):35-40. PubMed ID: 22903028 [TBL] [Abstract][Full Text] [Related]
15. Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Campos-Melo D; Droppelmann CA; He Z; Volkening K; Strong MJ Mol Brain; 2013 May; 6():26. PubMed ID: 23705811 [TBL] [Abstract][Full Text] [Related]
16. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Chen Y; Wei Q; Chen X; Li C; Cao B; Ou R; Hadano S; Shang HF Front Mol Neurosci; 2016; 9():69. PubMed ID: 27582688 [TBL] [Abstract][Full Text] [Related]
17. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897 [TBL] [Abstract][Full Text] [Related]
18. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844 [TBL] [Abstract][Full Text] [Related]
19. Network strategy to investigate differential pathways in sporadic amyotrophic lateral sclerosis. Han LH; Fan XY; Guo H; Wei W; Chen MM; Yan SF J Cancer Res Ther; 2018 Dec; 14(Supplement):S1057-S1062. PubMed ID: 30539846 [TBL] [Abstract][Full Text] [Related]
20. A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis. Kumar R; Malik MZ; Thanaraj TA; Bagabir SA; Haque S; Tambuwala M; Haider S Cell Signal; 2023 Dec; 112():110915. PubMed ID: 37838312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]